AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)

RecruitingPhase 2, Phase 3Ages 18 Years - 65 YearsAllAcademisch Medisch Centrum - Universiteit van Amsโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of this randomized controlled trial (RCT) is to evaluate the effectiveness of the MiLES intervention targeted at employers, on successful return to work (RTW) of employees with cancer, compared to care as usual (CAU). Secundary objectives are: * To evaluate the cost-effectiveness and return-on-investment of the MiLES intervention on successful RTW and quality of life, compared to CAU. * To evaluate the effectiveness of the MiLES intervention on several outcome measures on the level of the employee with cancer (time to RTW, quality of life, quality of working life, received work-related support, and satisfaction with work-related support), and the level of the employer (self-efficacy in providing RTW support, and satisfaction with the RTW process). Participants will be 140 employer-employee with cancer dyads. All dyads will randomly be allocated to the intervention group,

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria employees with cancer: * Diagnosed with cancer \<2 years earlier; * Being of working age (between 18-65 years, considering the Dutch retirement age of 67 years, and the study's follow-up period of one year); * In paid employment with an employer; * Having either an occupational physician at the involved occupational health service or a reintegration consultant at the involved reintegration service (e.g. working for an organization that is affiliated with one of the settings of this study); * Currently fully or partly sick-listed (\<2 years); * Able to understand and read Dutch for filling out questionnaires; * Having already informed their employer about their diagnosis of cancer, or intending to do so; * Not yet applied or planning to apply for an invalidity benefit under the WIA. Inclusion criteria employers: * Supports and guides the participating employee with cancer during the period of sick leave and RTW. For example, as the direct supervisor or HR-manager; * Able to understand and read Dutch to be able to use the MiLES intervention and for filling out questionnaires; * Not yet familiar with the MiLES intervention. Exclusion Criteria: \- Employees with cancer and their employers must participate as a dyad. If one party in the dyad is unable or unwilling to participate, the other party cannot participate either.
๐Ÿ’Š

What it tests

  • MiLES
๐Ÿ“

Where

5 sites
Arbo Unie
Arnhem, Netherlands
Arbo Unie
Dordrecht, Netherlands
Arbo Unie
Hengelo, Netherlands
Re-turn
Utrecht, Netherlands
Arbo Unie
Zeeland, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy